Semiconductors
Compare Stocks
5 / 10Stock Comparison
ACMR vs ICHR vs UCTT vs AXTI vs CAMT
Revenue, margins, valuation, and 5-year total return — side by side.
Semiconductors
Semiconductors
Semiconductors
Semiconductors
ACMR vs ICHR vs UCTT vs AXTI vs CAMT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Semiconductors | Semiconductors | Semiconductors | Semiconductors | Semiconductors |
| Market Cap | $3.92B | $2.47B | $3.63B | $4.76B | $7.18B |
| Revenue (TTM) | $901M | $959M | $2.07B | $88M | $472M |
| Net Income (TTM) | $94M | $-51M | $-194M | $-21M | $134M |
| Gross Margin | 44.4% | 11.3% | 15.6% | 12.7% | 50.3% |
| Operating Margin | 12.1% | -3.8% | -5.3% | -24.9% | 26.6% |
| Forward P/E | 29.7x | 62.2x | 34.4x | 3831.1x | 55.5x |
| Total Debt | $303M | $186M | $810M | $66M | $207M |
| Cash & Equiv. | $766M | $98M | $312M | $128M | $126M |
ACMR vs ICHR vs UCTT vs AXTI vs CAMT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| ACM Research, Inc. (ACMR) | 100 | 297.0 | +197.0% |
| Ichor Holdings, Ltd. (ICHR) | 100 | 313.1 | +213.1% |
| Ultra Clean Holding… (UCTT) | 100 | 385.4 | +285.4% |
| AXT, Inc. (AXTI) | 100 | 2049.5 | +1949.5% |
| Camtek Ltd. (CAMT) | 100 | 1497.9 | +1397.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ACMR vs ICHR vs UCTT vs AXTI vs CAMT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ACMR is the #2 pick in this set and the best alternative if valuation efficiency is your priority.
- PEG 0.84 vs CAMT's 1.59
- Lower P/E (29.7x vs 55.5x), PEG 0.84 vs 1.59
ICHR lags the leaders in this set but could rank higher in a more targeted comparison.
Among these 5 stocks, UCTT doesn't own a clear edge in any measured category.
AXTI ranks third and is worth considering specifically for momentum.
- +83.7% vs CAMT's +177.5%
CAMT carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 2 yrs, beta 1.99, yield 0.6%
- Rev growth 36.1%, EPS growth 50.3%, 3Y rev CAGR 16.8%
- 106.7% 10Y total return vs AXTI's 33.6%
- Lower volatility, beta 1.99, Low D/E 37.7%, current ratio 5.00x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 36.1% revenue growth vs AXTI's -11.1% | |
| Value | Lower P/E (29.7x vs 55.5x), PEG 0.84 vs 1.59 | |
| Quality / Margins | 28.4% margin vs AXTI's -24.1% | |
| Stability / Safety | Beta 1.99 vs AXTI's 4.18 | |
| Dividends | 0.6% yield, 2-year raise streak, vs ACMR's 0.2%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +83.7% vs CAMT's +177.5% | |
| Efficiency (ROA) | 13.7% ROA vs UCTT's -11.0%, ROIC 13.7% vs 2.6% |
ACMR vs ICHR vs UCTT vs AXTI vs CAMT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
ACMR vs ICHR vs UCTT vs AXTI vs CAMT — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CAMT leads in 2 of 6 categories
ACMR leads 1 • AXTI leads 1 • ICHR leads 0 • UCTT leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
CAMT leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
UCTT is the larger business by revenue, generating $2.1B annually — 23.4x AXTI's $88M. CAMT is the more profitable business, keeping 28.4% of every revenue dollar as net income compared to AXTI's -24.1%. On growth, CAMT holds the edge at +20.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $901M | $959M | $2.1B | $88M | $472M |
| EBITDAEarnings before interest/tax | $126M | -$11M | -$52M | -$13M | $161M |
| Net IncomeAfter-tax profit | $94M | -$51M | -$194M | -$21M | $134M |
| Free Cash FlowCash after capex | -$69M | -$17M | -$44M | -$19M | $0 |
| Gross MarginGross profit ÷ Revenue | +44.4% | +11.3% | +15.6% | +12.7% | +50.3% |
| Operating MarginEBIT ÷ Revenue | +12.1% | -3.8% | -5.3% | -24.9% | +26.6% |
| Net MarginNet income ÷ Revenue | +10.4% | -5.3% | -9.4% | -24.1% | +28.4% |
| FCF MarginFCF ÷ Revenue | -7.6% | -1.7% | -2.1% | -21.3% | +26.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | +9.4% | +4.7% | +2.9% | -8.2% | +20.2% |
| EPS Growth (YoY)Latest quarter vs prior year | -76.1% | +46.2% | -2.6% | +33.0% | +21.1% |
Valuation Metrics
ACMR leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 43.2x trailing earnings, ACMR trades at a 46% valuation discount to CAMT's 79.8x P/E. Adjusting for growth (PEG ratio), ACMR offers better value at 1.22x vs CAMT's 2.28x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $3.9B | $2.5B | $3.6B | $4.8B | $7.2B |
| Enterprise ValueMkt cap + debt − cash | $3.5B | $2.6B | $4.1B | $4.7B | $7.3B |
| Trailing P/EPrice ÷ TTM EPS | 43.21x | -46.25x | -19.98x | -221.27x | 79.79x |
| Forward P/EPrice ÷ next-FY EPS est. | 29.68x | 62.25x | 34.44x | 3831.10x | 55.49x |
| PEG RatioP/E ÷ EPS growth rate | 1.22x | — | — | — | 2.28x |
| EV / EBITDAEnterprise value multiple | 27.49x | — | 34.53x | — | — |
| Price / SalesMarket cap ÷ Revenue | 4.35x | 2.61x | 1.77x | 53.94x | — |
| Price / BookPrice ÷ Book value/share | 2.06x | 3.67x | 4.62x | 14.23x | 17.36x |
| Price / FCFMarket cap ÷ FCF | — | — | 247.26x | — | — |
Profitability & Efficiency
CAMT leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
CAMT delivers a 21.4% return on equity — every $100 of shareholder capital generates $21 in annual profit, vs $-25 for UCTT. ACMR carries lower financial leverage with a 0.16x debt-to-equity ratio, signaling a more conservative balance sheet compared to UCTT's 1.03x. On the Piotroski fundamental quality scale (0–9), CAMT scores 7/9 vs AXTI's 2/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +6.1% | -7.5% | -25.4% | -8.0% | +21.4% |
| ROA (TTM)Return on assets | +3.9% | -5.2% | -11.0% | -5.9% | +13.7% |
| ROICReturn on invested capital | +7.0% | -3.9% | +2.6% | -6.0% | +13.7% |
| ROCEReturn on capital employed | +6.6% | -4.7% | +2.9% | -7.2% | +14.8% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 3 | 5 | 2 | 7 |
| Debt / EquityFinancial leverage | 0.16x | 0.28x | 1.03x | 0.20x | 0.38x |
| Net DebtTotal debt minus cash | -$463M | $87M | $499M | -$63M | $81M |
| Cash & Equiv.Liquid assets | $766M | $98M | $312M | $128M | $126M |
| Total DebtShort + long-term debt | $303M | $186M | $810M | $66M | $207M |
| Interest CoverageEBIT ÷ Interest expense | 20.44x | -5.97x | -5.80x | -17.48x | 4356.62x |
Total Returns (Dividends Reinvested)
AXTI leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in AXTI five years ago would be worth $112,236 today (with dividends reinvested), compared to $12,895 for ICHR. Over the past 12 months, AXTI leads with a +8370.3% total return vs CAMT's +177.5%. The 3-year compound annual growth rate (CAGR) favors AXTI at 2.3% vs ICHR's 35.9% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +31.9% | +249.0% | +192.5% | +546.9% | +67.2% |
| 1-Year ReturnPast 12 months | +195.6% | +329.1% | +312.7% | +8370.3% | +177.5% |
| 3-Year ReturnCumulative with dividends | +487.9% | +151.1% | +187.5% | +3420.1% | +603.4% |
| 5-Year ReturnCumulative with dividends | +133.4% | +28.9% | +59.4% | +1022.4% | +526.7% |
| 10-Year ReturnCumulative with dividends | +3065.8% | +629.1% | +1385.1% | +3363.9% | +10665.7% |
| CAGR (3Y)Annualised 3-year return | +80.5% | +35.9% | +42.2% | +2.3% | +91.6% |
Risk & Volatility
Evenly matched — AXTI and CAMT each lead in 1 of 2 comparable metrics.
Risk & Volatility
CAMT is the less volatile stock with a 1.99 beta — it tends to amplify market swings less than AXTI's 4.18 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AXTI currently trades 97.9% from its 52-week high vs ACMR's 82.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 3.24x | 3.93x | 3.19x | 4.18x | 1.99x |
| 52-Week HighHighest price in past year | $71.65 | $72.87 | $87.68 | $110.80 | $210.20 |
| 52-Week LowLowest price in past year | $19.26 | $13.12 | $18.52 | $1.23 | $62.88 |
| % of 52W HighCurrent price vs 52-week peak | +82.6% | +97.7% | +91.1% | +97.9% | +91.9% |
| RSI (14)Momentum oscillator 0–100 | 60.7 | 66.9 | 62.3 | 68.9 | 63.0 |
| Avg Volume (50D)Average daily shares traded | 1.2M | 795K | 1.3M | 12.3M | 401K |
Analyst Outlook
Evenly matched — ACMR and CAMT each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: ACMR as "Buy", ICHR as "Buy", UCTT as "Buy", AXTI as "Buy", CAMT as "Buy". Consensus price targets imply 6.4% upside for UCTT (target: $85) vs -51.7% for AXTI (target: $52). For income investors, CAMT offers the higher dividend yield at 0.63% vs ACMR's 0.19%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $40.00 | $49.80 | $85.00 | $52.40 | $165.60 |
| # AnalystsCovering analysts | 10 | 14 | 12 | 11 | 13 |
| Dividend YieldAnnual dividend ÷ price | +0.2% | — | — | — | +0.6% |
| Dividend StreakConsecutive years of raises | 3 | 1 | 1 | 1 | 2 |
| Dividend / ShareAnnual DPS | $0.11 | — | — | — | $1.22 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.2% | 0.0% | +0.1% | 0.0% | — |
CAMT leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). ACMR leads in 1 (Valuation Metrics). 2 tied.
ACMR vs ICHR vs UCTT vs AXTI vs CAMT: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is ACMR or ICHR or UCTT or AXTI or CAMT a better buy right now?
For growth investors, Camtek Ltd.
(CAMT) is the stronger pick with 36. 1% revenue growth year-over-year, versus -11. 1% for AXT, Inc. (AXTI). ACM Research, Inc. (ACMR) offers the better valuation at 43. 2x trailing P/E (29. 7x forward), making it the more compelling value choice. Analysts rate ACM Research, Inc. (ACMR) a "Buy" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ACMR or ICHR or UCTT or AXTI or CAMT?
On trailing P/E, ACM Research, Inc.
(ACMR) is the cheapest at 43. 2x versus Camtek Ltd. at 79. 8x. On forward P/E, ACM Research, Inc. is actually cheaper at 29. 7x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: ACM Research, Inc. wins at 0. 84x versus Camtek Ltd. 's 1. 59x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — ACMR or ICHR or UCTT or AXTI or CAMT?
Over the past 5 years, AXT, Inc.
(AXTI) delivered a total return of +1022%, compared to +28. 9% for Ichor Holdings, Ltd. (ICHR). Over 10 years, the gap is even starker: CAMT returned +106. 7% versus ICHR's +629. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ACMR or ICHR or UCTT or AXTI or CAMT?
By beta (market sensitivity over 5 years), Camtek Ltd.
(CAMT) is the lower-risk stock at 1. 99β versus AXT, Inc. 's 4. 18β — meaning AXTI is approximately 109% more volatile than CAMT relative to the S&P 500. On balance sheet safety, ACM Research, Inc. (ACMR) carries a lower debt/equity ratio of 16% versus 103% for Ultra Clean Holdings, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — ACMR or ICHR or UCTT or AXTI or CAMT?
By revenue growth (latest reported year), Camtek Ltd.
(CAMT) is pulling ahead at 36. 1% versus -11. 1% for AXT, Inc. (AXTI). On earnings-per-share growth, the picture is similar: Camtek Ltd. grew EPS 50. 3% year-over-year, compared to -869. 2% for Ultra Clean Holdings, Inc.. Over a 3-year CAGR, ACMR leads at 32. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ACMR or ICHR or UCTT or AXTI or CAMT?
Camtek Ltd.
(CAMT) is the more profitable company, earning 27. 6% net margin versus -24. 1% for AXT, Inc. — meaning it keeps 27. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CAMT leads at 25. 2% versus -24. 9% for AXTI. At the gross margin level — before operating expenses — CAMT leads at 48. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ACMR or ICHR or UCTT or AXTI or CAMT more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, ACM Research, Inc. (ACMR) is the more undervalued stock at a PEG of 0. 84x versus Camtek Ltd. 's 1. 59x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, ACM Research, Inc. (ACMR) trades at 29. 7x forward P/E versus 3831. 1x for AXT, Inc. — 3801. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for UCTT: 6. 4% to $85. 00.
08Which pays a better dividend — ACMR or ICHR or UCTT or AXTI or CAMT?
In this comparison, CAMT (0.
6% yield), ACMR (0. 2% yield) pay a dividend. ICHR, UCTT, AXTI do not pay a meaningful dividend and should not be held primarily for income.
09Is ACMR or ICHR or UCTT or AXTI or CAMT better for a retirement portfolio?
For long-horizon retirement investors, Ultra Clean Holdings, Inc.
(UCTT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+1385% 10Y return). ACM Research, Inc. (ACMR) carries a higher beta of 3. 24 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (UCTT: +1385%, ACMR: +30. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ACMR and ICHR and UCTT and AXTI and CAMT?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: ACMR is a small-cap high-growth stock; ICHR is a small-cap quality compounder stock; UCTT is a small-cap quality compounder stock; AXTI is a small-cap quality compounder stock; CAMT is a small-cap high-growth stock. CAMT pays a dividend while ACMR, ICHR, UCTT, AXTI do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.